Reframe everyday life for millions living with chronic kidney disease

Chronic kidney disease is one of the fastest-growing health problems in the world

Globally, CKD is projected to be the fifth most common cause of mortality by 2040.

Now is the time to get ahead of the curve. And KAREL is looking for investment partners who want to make it happen.

Join us on our mission to take on this silent killer. In the process, we’ll save healthcare systems some of the $130 billion spent each year on CKD by empowering hundreds of millions of patients around the world through self-managed care.

KAREL is on the lookout for the newest health tech innovations to share with the CKD patient community.

From the latest in artificial intelligence to the best-in-class connected devices, we want to collaborate! 

If you want to know more about working with us to improve patient wellbeing and grow access to healthcare on a global scale, please get in touch today.

KAREL partners with pharmaceutical companies to test new drugs, track medication adherence, and advance innovative methods of care.

If this sounds like you, get in touch today!

Patients with chronic kidney disease take mountains of medication every day.

KAREL works with pharmacies around the world to give these patients access to the latest in prescription management and delivery options.

Chronic kidney disease is preventable when the right measures are taken early.

Empower your insurance members dealing with chronic kidney disease and improve their health outcomes with KAREL.